文献速递脑血管病外科神经重症

蛛网膜下腔出血后复发性脑血管痉挛患者的重复血管内治疗:一种值得的策略?

Repeated Endovascular Treatments in Patients with Recurrent Cerebral Vasospasms After Subarachnoid Hemorrhage: A Worthwhile Strategy?
PubMed 文献 · World Neurosurg · 2018-02-01

本研究回顾15例因复发性症状性脑血管痉挛接受2次以上血管内治疗的蛛网膜下腔出血患者,并与按年龄、WFNS评分、Fisher分级和治疗方式个体匹配的无症状性脑血管痉挛对照组比较。结果显示重复治疗组机械通气时间更长、气管切开和分流依赖性脑积水比例更高,血管造影及CTP/CTA检查次数和辐射剂量显著更高(P<0.001),3个月不良结局(mRS 3-6)比例无显著差异,但6个月时至少5/14例获得良好结局。作者认为重复血管内治疗复杂且辐射剂量高,但在原本状况较差的患者中仍可取得良好结果。

要点

  • 15例复发性症状性脑血管痉挛患者共接受70次血管内治疗,3个月不良结局(mRS 3-6)为6/15 vs 对照组2/15,无显著差异。
  • 重复治疗组血管造影中位数5次 vs 2次、CTP/CTA中位数4次 vs 1次,辐射剂量显著更高(P<0.001)。
  • 6个月时至少5/14例重复治疗患者获得良好结局,作者认为在原本状况较差的患者中仍可取得良好结果。

核心结论

  • 作者认为,对蛛网膜下腔出血后复发性脑血管痉挛患者进行重复血管内治疗复杂且使患者暴露于高辐射剂量,但在原本状况较差的患者中仍可取得良好结果。

研究设计与样本

  • 回顾性分析15例蛛网膜下腔出血后因复发性症状性脑血管痉挛接受2次以上血管内治疗的患者(CVS组),并与按年龄、WFNS评分、Fisher分级和治疗方式个体匹配的无症状性脑血管痉挛蛛网膜下腔出血患者作为对照组(非CVS组)。

主要发现

  • CVS组共接受70次血管内治疗。
  • CVS组机械通气时间585天 vs 非CVS组439天,气管切开12/15 vs 7/15,分流依赖性脑积水6/15 vs 2/15。
  • CVS组血管造影中位数5次 vs 2次、CTP/CTA中位数4次 vs 1次,辐射剂量显著更高(P<0.001)。
  • 3个月不良结局(mRS 3-6)CVS组6/15 vs 非CVS组2/15,无显著差异;6个月时CVS组至少5/14例获得良好结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endovascular interventions in patients with subarachnoid hemorrhage (SAH) and symptomatic cerebral vasospasm (sCVS) are commonly performed, but the potential benefits of repeated interventions have not been proven. The aim of this study was to show the potential burden and opportunities of repeated endovascular interventions in cases of recurrent sCVS. METHODS: We reviewed 15 patients with SAH who underwent more than 2 endovascular treatments of recurrent sCVS (CVS group) regarding the radiation doses, their clinical course, and their functional outcome. A case-control group of SAH patients without sCVS individually matched for age, World Federation of Neurosurgical Societies score, Fisher grade, and treatment modality was used as control group (non-CVS group). RESULTS: A total of 70 endovascular treatments were performed in the CVS group. CVS group patients received longer mechanical ventilation (585 days vs. 439 days) and showed a higher rate of tracheostomy (12/15 vs. 7/15) and shunt-dependent hydrocephalus (6/15 vs. 2/15) than did the non-CVS patients. Moreover, patients from the CVS group underwent significantly (P < 0.001) more angiographies (median, 5 vs. 2) and CTP/CTA scans (median, 4 vs. 1) and consequently received significantly (P < 0.001) higher radiation doses. The rate of unfavorable outcomes (mRS 3-6) after 3 months was nonsignificantly higher in the CVS group (6/15 vs. 2/15), but after 6 months at least 5/14 patients from the CVS group showed a favorable outcome. CONCLUSION: Repeated endovascular treatments of SAH patients with recurrent CVS are complex and expose the patients to high radiation doses. Nevertheless, favorable results could be achieved in patients in otherwise poor condition.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ditz C, Neumann A, Wojak J, et al. Repeated Endovascular Treatments in Patients with Recurrent Cerebral Vasospasms After Subarachnoid Hemorrhage: A Worthwhile Strategy? World Neurosurg. 2018. PMID: 29410034. doi:10.1016/j.wneu.2018.01.156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。